AssetMark Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-512
| Closed | -$52.7K | – | 1831 |
|
|
2023
Q2 | $52.7K | Buy |
512
+126
| +33% | +$13K | ﹤0.01% | 1062 |
|
|
2023
Q1 | $42.1K | Sell |
386
-702
| -65% | -$76.6K | ﹤0.01% | 1072 |
|
|
2022
Q4 | $124K | Buy |
1,088
+55
| +5% | +$6.26K | ﹤0.01% | 883 |
|
|
2022
Q3 | $64K | Buy |
1,033
+131
| +15% | +$8.12K | ﹤0.01% | 903 |
|
|
2022
Q2 | $72K | Buy |
902
+565
| +168% | +$45.1K | ﹤0.01% | 864 |
|
|
2022
Q1 | $35K | Buy |
+337
| New | +$35K | ﹤0.01% | 986 |
|
|
2021
Q2 | – | Sell |
-2
| Closed | – | – | 1612 |
|
|
2021
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 1590 |
|
|
2020
Q4 | $0 | Sell |
2
-11
| -85% | – | ﹤0.01% | 1528 |
|
|
2020
Q3 | $1K | Sell |
13
-8,482
| -100% | -$652K | ﹤0.01% | 1303 |
|
|
2020
Q2 | $472K | Sell |
8,495
-141,319
| -94% | -$7.85M | ﹤0.01% | 393 |
|
|
2020
Q1 | $4.44M | Buy |
149,814
+60,625
| +68% | +$1.8M | 0.04% | 227 |
|
|
2019
Q4 | $3.23M | Buy |
89,189
+89,072
| +76,130% | +$3.22M | 0.02% | 284 |
|
|
2019
Q3 | $3K | Buy |
117
+26
| +29% | +$667 | ﹤0.01% | 1137 |
|
|
2019
Q2 | $2K | Buy |
91
+29
| +47% | +$637 | ﹤0.01% | 1205 |
|
|
2019
Q1 | $2K | Buy |
62
+18
| +41% | +$581 | ﹤0.01% | 1208 |
|
|
2018
Q4 | $1K | Hold |
44
| – | – | ﹤0.01% | 1403 |
|
|
2018
Q3 | $1K | Sell |
44
-11
| -20% | -$250 | ﹤0.01% | 1390 |
|
|
2018
Q2 | $1K | Hold |
55
| – | – | ﹤0.01% | 1387 |
|
|
2018
Q1 | $1K | Buy |
55
+13
| +31% | +$236 | ﹤0.01% | 1385 |
|
|
2017
Q4 | $1K | Buy |
+42
| New | +$1K | ﹤0.01% | 1812 |
|
|
2016
Q1 | – | Sell |
-47
| Closed | -$1K | – | 1502 |
|
|
2015
Q4 | $1K | Buy |
47
+34
| +262% | +$723 | ﹤0.01% | 1325 |
|
|
2015
Q3 | $0 | Buy |
+13
| New | – | ﹤0.01% | 896 |
|